Research Center Of Neurology 1
1. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
2. Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
3. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019
4. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
5. Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission
6. Usability and feasibility of PreventS-MD web app for stroke prevention
7. Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease
8. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
9. Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2) (npj Parkinsons Disease, (2023), 9, 1, (100), 10.1038/s41531-023-00526-9)
10. The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
11. Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset
12. The burden of diseases, injuries, and risk factors by state in the USA, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
13. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
14. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
15. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
16. Retraction Note: The randomized clinical trial results of the anxiety treatment in patients with somatoform dysfunction and neurotic disorders (Sci Rep, (2021), 11, (24282), 10.1038/s41598-021-03727-5)
17. The randomized clinical trial results of the anxiety treatment in patients with somatoform dysfunction and neurotic disorders
18. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
19. Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scores
20. TMEM175, SCARB2 and CTSB associations with Parkinson’s disease risk across populations
21. Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
1